Diagnostic performance of the Xpert MTB/RIF assay in BAL fluid samples from patients under clinical suspicion of pulmonary tuberculosis: a tertiary care experience in a high-tuberculosis-burden area.
Guilherme Machado Xavier de BritoThiago Thomaz MafortMarcelo Ribeiro AlvesLarissa Vieira Tavares Dos ReisJanaina LeungRobson Souza LeãoRogerio Lopes Rufino AlvesLuciana Silva RodriguesPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2021)
In BALF samples, the Xpert MTB/RIF assay performs better than do traditional methods, providing a reliable alternative to sputum analysis in suspected cases of PTB. However, the rate of discordant results merits careful consideration.
Keyphrases
- pulmonary tuberculosis
- mycobacterium tuberculosis
- tertiary care
- end stage renal disease
- high throughput
- newly diagnosed
- ejection fraction
- chronic kidney disease
- pulmonary embolism
- prognostic factors
- emergency department
- peritoneal dialysis
- hepatitis c virus
- hiv infected
- adverse drug
- patient reported
- antiretroviral therapy
- data analysis